Home  ›  GenBody America  ›  GenBody COVID-19 Antigen Rapid Test (25/box)
GENBODY COVID-19 ANTIGEN RAPID TEST (25 PER BOX)
GENBODY COVID-19 ANTIGEN RAPID TEST (25 PER BOX)

GenBody COVID-19 Antigen Rapid Test (25/box)

Regular price $295.00
Sale price $295.00 Regular price
Unit price
Save
In Stock
Rendering loop-subscriptions
A rapid, CLIA-waived antigen test for SARS-CoV-2 detection.
  • Rapid Results
  • CLIA-Waived Test
  • High Sensitivity & Specificity
  • User-Friendly Design
  • Portable and Convenient
Choose your purchase type:

Subscription Details:

  • Save 10-15% on all subscription orders!
  • Cancel anytime from your customer portal.
  • Super flexible subscription controls.
  • SMS/email notifications on upcoming orders.
  • Choose your delivery schedule:
Pickup available at PHARMALYNK WAREHOUSE

Usually ready in 4 hours

  • All orders ship the same day (Free $250+)

  • Save 10% — on auto-renew orders.

  • Wholesale Program available

An industry leading provider of rapid, Point of Care professional diagnostic solutions.

GenBody is a diversified manufacturer of diagnostic tests for over 78 human diseases. With more than 20 years combined experience in the diagnostic industry and through its vast network between several key institutes, universities and hospitals, our core strength is in R&D. GenBody specializes in developing monoclonal antibodies and recombinant antigens in-house at our facility in South Korea.

FAQs

The Genbody COVID-19 Ag Test is designed to detect active SARS-CoV-2 infections through rapid antigen testing at point-of-care settings.

Yes, the Genbody COVID-19 Ag Test is CLIA-waived, making it suitable for use in compliant settings like clinics, schools, and workplaces.

The test offers high sensitivity and specificity for reliable detection of COVID-19 infections.

About GenBody America
A diversified manufacturer of diagnostic tests for over 78 human diseases.
GenBody is a diversified manufacturer of diagnostic tests for over 78 human diseases. With more than 20 years combined experience in the diagnostic industry and through its vast network between several key institutes, universities and hospitals, our core strength is in R&D. GenBody specializes in developing monoclonal antibodies and recombinant antigens.